CN1233471A - Medicinal prepns. for treating underarm odour and beriberi - Google Patents
Medicinal prepns. for treating underarm odour and beriberi Download PDFInfo
- Publication number
- CN1233471A CN1233471A CN 98126487 CN98126487A CN1233471A CN 1233471 A CN1233471 A CN 1233471A CN 98126487 CN98126487 CN 98126487 CN 98126487 A CN98126487 A CN 98126487A CN 1233471 A CN1233471 A CN 1233471A
- Authority
- CN
- China
- Prior art keywords
- milliliters
- medicine
- beriberi
- bromhidrosis
- distilled water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a medicine for treating bromhidriosis and berberi and is prepd. by compounding formaldehyde, potassium permanganate and distilled water according to a certain proportion. It is an external use medical liquid which not only can treat bromhidrosis and beriberi radically, but also has no harm to sweat gland and foot skin. Its curing rate can be up to 100%.
Description
The invention belongs to the medicine of treatment bromhidrosis and beriberi.
Bromhidrosis and beriberi all are the diseases that are difficult to radical cure.Present more existing medicines, silver-colored osmanthus board Liquor Flos osmanthi Distillata (fetid sweat spirit) as the agent factory production of applying ointment outside the Lingchuan County, Guangxi, the XISHILANXIALU that Henan sislan joint enterprise company limited is produced, the daktarin that the JIAOXIAN YICIJING that the magical pharmaceutical factory in Guizhou produces and Xian-Janssen Pharmaceutical Ltd. produce, though to treatment bromhidrosis or beriberi, all have in a short time than positive effect, but can not reach the effect of thorough eradication therapy, soon just recurrence again of bromhidrosis or beriberi, and have medicinal after cause chapped skin damage, bring misery to the patient.So invent and a kind ofly can effect a radical cure bromhidrosis and beriberi, the new drug of injured skin does not become the task of top priority again.
The object of the present invention is to provide a kind of quick radical cure bromhidrosis and the beriberi novel drugs of injured skin not again.
The technical solution used in the present invention is: the medicine of this treatment bromhidrosis and beriberi is mixed with externally applied liquid by a certain percentage by formaldehyde, potassium permanganate and distilled water basically.
Because formaldehyde has the function of sterilization, the unlikely damage of protection cell, the function that potassium permanganate has the disinfection deodorization and the atrophy of bromhidrosis body of gland is eliminated, distilled water has diluting effect, and above-mentioned composition is rationally prepared according to the science ratio, so medicine of the present invention is on probation through many cases bromhidrosis, beriberi patient, can eradicate bromhidrosis and beriberi fast, no longer recurrence, cure rate reaches 100%, and does not destroy the oxter sweat gland, bromhidrosis patient has eradicated with the back bromhidrosis, and axillary fossa is perspired as usual; Injured skin not, beriberi patient with rear foot aerial root except, but the not dry and cracked damage of foot skin skin.
Below in conjunction with specific embodiment the present invention is described in further detail.
Embodiment one, medicine of the present invention are basically by formaldehyde HCHO, potassium permanganate KM
nO
4With distilled water H
2O is formulated by a certain percentage, is liquid.
The volume mass content value scope of this each composition of medicinal liquid can be selected in: 20 milliliters～30 milliliters of the formalins of purity 36%, potassium permanganate 0.5 gram～1.5 grams, 165 milliliters～185 milliliters of distilled water.
Earlier 20 milliliters～30 milliliters of the formalins of purity 36% are dissolved in during concrete preparation in 70 milliliters～80 milliliters the distilled water, potassium permanganate with 0.5 gram～1.5 grams are dissolved in 95 milliliters～105 milliliters the distilled water again, more above-mentioned two kinds of solution are hybridly prepared into medicinal liquid.
In addition, the volume of this each composition of medicinal liquid, mass content value also can preferably be decided to be: 25 milliliters of the formalins of purity 36%, potassium permanganate 1 gram, 175 milliliters of distilled water.
Earlier 25 milliliters of the formalins of purity 36% are dissolved in during concrete preparation in 75 milliliters the distilled water, again the potassium permanganate of 1 gram are dissolved in 100 milliliters the distilled water, more above-mentioned two kinds of solution are hybridly prepared into medicinal liquid.
Embodiment two, as adding ethanol CH in embodiment one medicine components
3CH
2This new composition of OH, ethanol can strengthen the disinfection ability on the one hand, also can impel potassium permanganate to be easier to dissolving on the other hand.
The volume mass content value scope of this each composition of medicinal liquid is: 20 milliliters～30 milliliters of the formalins of purity 36%, potassium permanganate 0.5 gram～1.5 grams, 70 milliliters～80 milliliters of distilled water, 90 milliliters～110 milliliters of ethanol.
In addition, each composition volume mass content value of this medicinal liquid can preferably be decided to be: 25 milliliters of the formalins of purity 36%, potassium permanganate 1 gram, 75 milliliters of distilled water, 100 milliliters of ethanol.
When medicinal liquid was specifically prepared, the formalin with purity 36% was dissolved in the distilled water earlier, potassium permanganate is dissolved in the ethanol again, and above-mentioned two kinds of solution are hybridly prepared into medicinal liquid.
Medicinal liquid of the present invention is outer applying ointment, and medicinal liquid directly can be put on the skin behind the skin clean and is coated in oxter or foot, and a week uses once, and light disease person once eradicates, and serious symptom person eradicates for three to four times.Traumatic patient, as bump brokenly, knife scratches and to bleed and skin ulcer disease person forbidding.
Claims (6)
1, a kind of medicine for the treatment of bromhidrosis and beriberi is characterized in that: this medicine is basically by formaldehyde HCHO, potassium permanganate KM
nO
4, distilled water H
2O is formulated by a certain percentage, is liquid.
2, a kind of medicine for the treatment of bromhidrosis and beriberi according to claim 1 is characterized in that: also contain ethanol CH in its medicine composition
3CH
2OH.
3, a kind of medicine for the treatment of bromhidrosis and beriberi according to claim 1 is characterized in that: each composition volume mass content range value of its medicine is: 20 milliliters～30 milliliters of the formaldehyde HCHO solution of purity 36%, potassium permanganate KM
nO
40.5 gram～1.5 grams, distilled water H
2165 milliliters～185 milliliters of O.
4, a kind of medicine for the treatment of bromhidrosis and beriberi according to claim 2 is characterized in that: each composition volume mass content range value of its medicine is: 20 milliliters～30 milliliters of the formaldehyde HCHO solution of purity 36%, potassium permanganate KM
nO
40.5 gram～1.5 grams, distilled water H
270 milliliters～80 milliliters of O, ethanol CH
3CH
2OH 90 milliliters～110 millis are opened.
5, a kind of medicine for the treatment of bromhidrosis and beriberi according to claim 3 is characterized in that: each composition volume mass content value of certain medicine can preferably be decided to be: 25 milliliters of the formaldehyde HCHO solution of purity 36%, potassium permanganate KM
nO
41 gram, distilled water H
2175 milliliters of O.
6, a kind of medicine for the treatment of bromhidrosis and beriberi according to claim 4 is characterized in that: each composition volume mass content value of its medicine can preferably be decided to be: 25 milliliters of the formaldehyde HCHO solution of purity 36%, potassium permanganate KM
nO
41 gram, distilled water H
275 milliliters of O, ethanol CH
3CH
2100 milliliters of OH.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98126487A CN1105561C (en) | 1998-12-31 | 1998-12-31 | Medicinal prepns. for treating underarm odour and beriberi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98126487A CN1105561C (en) | 1998-12-31 | 1998-12-31 | Medicinal prepns. for treating underarm odour and beriberi |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1233471A true CN1233471A (en) | 1999-11-03 |
| CN1105561C CN1105561C (en) | 2003-04-16 |
Family
ID=5229697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98126487A Expired - Fee Related CN1105561C (en) | 1998-12-31 | 1998-12-31 | Medicinal prepns. for treating underarm odour and beriberi |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1105561C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885697A (en) * | 2011-07-22 | 2013-01-23 | 陈进民 | Inflammation diminishing and sterilizing flower perfume and preparation method thereof |
| CN106727694A (en) * | 2016-12-01 | 2017-05-31 | 葛龙海 | The external application bactericide of chronic inflammation is treated extensively |
-
1998
- 1998-12-31 CN CN98126487A patent/CN1105561C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102885697A (en) * | 2011-07-22 | 2013-01-23 | 陈进民 | Inflammation diminishing and sterilizing flower perfume and preparation method thereof |
| CN106727694A (en) * | 2016-12-01 | 2017-05-31 | 葛龙海 | The external application bactericide of chronic inflammation is treated extensively |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1105561C (en) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103006923B (en) | Chinese medicinal liquid band-aid and preparation method | |
| US20070098671A1 (en) | Composition and method of treatment for irritated skin | |
| CN108261447B (en) | A spray film agent containing radix et rhizoma Rhei superfine powder for wound surface and its preparation method | |
| JP2003535131A (en) | Pharmaceutical composition suitable for pain relief, and its form and method of use | |
| CN104666496A (en) | Menthol ointment and preparation process thereof | |
| CN1105561C (en) | Medicinal prepns. for treating underarm odour and beriberi | |
| CN101579423B (en) | Medicament composition for treating beriberi and preparation method thereof | |
| CN1224406C (en) | Medical ointment Jiaoxuanxiao for treating beriberi | |
| CN1269495C (en) | Medicinal powder for treating beriberi | |
| CN102743587A (en) | External application wound repair liquid | |
| CN103191163B (en) | Skin wound repairing pharmaceutical composition | |
| CN1201762C (en) | A medicine for treating scald and burn, and method for preparing same | |
| CN1062128C (en) | Ointment for eliminating tinea | |
| CN101361938A (en) | Kibe paste containing natural zingiber oil | |
| CN1094264A (en) | Tobacco agent health article | |
| JPH11180889A (en) | Agent for treating dermatitis containing extracted ingredient from ganoderma lucidum karst. | |
| CN109394950A (en) | Externally used Mongolian medicine of set a broken bone and preparation method thereof | |
| CN100387249C (en) | Traditional Chinese medicine formulation for treating ulcer | |
| CN103585330B (en) | A kind of Chinese medicine composition for cutaneous fungal infection and preparation method thereof | |
| CN1086125C (en) | Externally used medicine for treating tinea | |
| RU2142811C1 (en) | Antiinflammatory and reparative agent | |
| CN102920997B (en) | Compound tinea ointment | |
| Guo et al. | Preparation and treatment for oral ulcer of quercetin and the drug-loaded chitosan composite material | |
| CN1989950A (en) | Sterilizing effective antipruritic application agent | |
| CN101015639A (en) | Red burn ointment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |